Elsevier BV

SHERPA: Unknown

People

  1. Vickers
    Vickers
  2. Eastham
    Eastham
  3. Ehdaie
    Ehdaie
  4. Motzer
    Motzer
  5. Benfante
    Benfante
  6. Touijer
    Touijer
  7. Vertosick
    Vertosick
  8. Russo
    Russo
  9. Solomon
    Solomon
  10. Bajorin
    Bajorin

Groups

  1. Department of Medicine (64)
  2. Surgery (55)
  3. Population Sciences Research Program (53)
  4. Solid Tumor Oncology Division (52)
  5. Epidemiology and Biostatistics (47)
  6. Urology (43)
  7. Survivorship Research (31)
  8. Genitourinary Oncology Service (29)
  9. Health Outcomes Research Group (28)
  10. Sloan Kettering Institute Postdocs (26)
Search Within
Formats
  1. Journal Article (117)
  2. Review (20)
  3. Editorial (11)
  4. Research Letter (8)
  5. Correspondence (2)
  6. Conference Paper (1)
  7. Guidelines (1)
  8. Meeting Abstract (1)
Groups
  1. Department of Medicine (64)
  2. Surgery (55)
  3. Population Sciences Research Program (53)
  4. Solid Tumor Oncology Division (52)
  5. Epidemiology and Biostatistics (47)
  6. Urology (43)

More Groups

People
  1. Andrew Vickers (17)
  2. James Eastham (10)
  3. Behfar Ehdaie (9)
  4. Robert Motzer (9)
  5. Sigrid Carlsson (9)
  6. Karim Touijer (8)

More People

Years
  1. 2025 (21)
  2. 2024 (25)
  3. 2023 (35)
  4. 2022 (20)
  5. 2021 (15)
  6. 2020 (16)

More Years

Publications
  1. European Urology Oncology (58)
  2. JTO Clinical and Research Reports (25)
  3. European Urology Open Science (23)
  4. JAAD International (6)
  5. PEC Innovation (6)
  6. Integrative Medicine Research (5)

More Publications

Results (161)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Brief report: Clinical characteristics and outcomes of patients with thoracic SMARCA4-deficient undifferentiated tumors
    Journal Article

    Cooper, A. J.; Arfe, A.; Ricciuti, B.; Gagné, A.; Sholl, L. M.; Di Federico, A.; Awad, M. M.; Aldea, M.; Ghigna, M. R.; Grecea, M.; more...
    JTO Clinical and Research Reports (2025)

    Fulltext@MSK | Save
  • The role of baseline prostate-specific antigen value prior to age 60 in predicting lethal prostate cancer: Analysis of a contemporary North American cohort
    Journal Article

    Finati, M.; Davis, M.; Stephens, A.; Chiarelli, G.; Cirulli, G. O.; Morrison, C.; Affas, R.; Sood, A.; Buffi, N.; Lughezzani, G.; more...
    European Urology Oncology (2024)

    Fulltext@MSK | Save
  • Realizing the scope of venous and arterial thrombosis in cyclin-dependent kinase 4/6 inhibitors in hormone positive breast cancer
    Editorial

    Wilkins, C. R.; Zwicker, J. I.
    European Journal of Internal Medicine (2024)

    Fulltext@MSK | Save
  • FITM2 deficiency results in ER lipid accumulation, ER stress, and reduced apolipoprotein B lipidation and VLDL triglyceride secretion in vitro and in mouse liver
    Journal Article

    Wang, H.; Nikain, C.; Fortounas, K. I.; Amengual, J.; Tufanli, O.; La Forest, M.; Yu, Y.; Wang, M. C.; Watts, R.; Lehner, R.; more...
    Molecular Metabolism (2024)

    Fulltext@MSK | Save
  • First report of response to tarlatamab in a patient with DLL3-positive pulmonary carcinoid: Case report
    Journal Article

    Cooper, A. J.; Rekhtman, N.; Baine, M. K.; Thomas, M. C.; Lynch, A. C.; Gentzler, R. D.
    JTO Clinical and Research Reports (2024)

    Fulltext@MSK | Save
  • The out-of-pocket cost of breast cancer care in Nigeria: A prospective analysis
    Journal Article

    Wuraola, F. O.; Blackman, C.; Olasehinde, O.; Aderounmu, A. A.; Adeleye, A.; Omoyiola, O. Z.; Kingham, T. P.; Fodero, R. F.; Adisa, A. O.; Lumati, J.; more...
    Journal of Cancer Policy (2024)

    Fulltext@MSK | Save
  • Symptom improvements and adverse effects with Reishi mushroom use: A cross-sectional survey of cancer patients
    Journal Article

    Li, X.; Sun, L.; Chimonas, S.; Li, S. Q.; Feng, P.; Yang, Y.; Mao, J. J.
    Integrative Medicine Research (2024)

    Fulltext@MSK | Save
  • ALKTERNATE: A pilot study alternating lorlatinib with crizotinib in ALK-positive NSCLC with prior ALK inhibitor resistance
    Journal Article

    Itchins, M.; Liang, S.; Brown, C.; Barnes, T.; Marx, G.; Chin, V.; Kao, S.; Yip, P. Y.; Mersiades, A. J.; Nagrial, A.; more...
    JTO Clinical and Research Reports (2024)

    Fulltext@MSK | Save
  • Three-year overall survival outcomes and correlative analyses in patients with NSCLC and high (50%–89%) versus very high (≥90%) programmed death-ligand 1 expression treated with first-line pembrolizumab or cemiplimab
    Journal Article

    Ricciuti, B.; Elkrief, A.; Lin, J.; Zhang, J.; Alessi, J. V.; Lamberti, G.; Gandhi, M.; Di Federico, A.; Pecci, F.; Wang, X.; more...
    JTO Clinical and Research Reports (2024)

    Fulltext@MSK | Save
  • Perioperative serum microRNA 371a-3p and 372-3p levels in patients with clinically localized testicular masses
    Journal Article

    Matulewicz, R. S.; Baky, F.; Knezevic, A.; Sheinfeld, J.; Williams, B. M.; Kantor, R. E.; Liso, N.; Hossain, J.; Bromberg, M.; Valentino, A.; more...
    European Urology Open Science (2024)

    Fulltext@MSK | Save

    • Elsevier BV – authorized name for: